跳至主要内容
临床试验/ACTRN12606000253505
ACTRN12606000253505招募中3 期

A pilot, double-blind crossover trial of the glucocorticoid antagonist mifepristone (RU-486) in the treatment of depression in patients with Parkinson's disease.

eurological Foundation0 个研究点目标入组 20 人开始时间: 2006年6月23日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • PD (UK Brain Bank criteria), DSM-IV Major Depressive Episode, Mini-mental state examination (MMSE) score >23.

排除标准

  • Depression complicated by active suicidal intent or requiring urgent treatment/hospitilisation, Current use steroid medications, Severe asthma/respiratory disease, Chronic adrenal, renal or hepatic failure, Females of child-bearing potential. Males and females eligible for study. Females of child-bearing potential are excluded.

研究者

发起方
eurological Foundation

相似试验